Price range: $319.00 through $439.00
Vyvanse is an approved first-line treatment for ADHD and binge-eating disorder. As a delayed-release medication, it has a lower abuse potential than other prescription stimulants, but “lower” does not mean that it cannot be abused recreationally.
Vyvanse is an approved first-line treatment for ADHD and binge-eating disorder. As a delayed-release medication, it has a lower abuse potential than other prescription stimulants, but “lower” does not mean that it cannot be abused recreationally.
| Quantity | 50, 100, 200 |
|---|
